Business Context and Reporting Period
This Form 8-K filing by The Clorox Company (CLOROX CO) was submitted on January 17, 2018. The report addresses significant changes in executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on personnel changes and associated compensation adjustments.
Material Changes
- Departure: Stephen M. Robb, Executive Vice President and Chief Financial Officer, announced his intention to retire on March 31, 2018, after 29 years of service. He will serve in an advisory capacity through the end of the fiscal year.
- Appointment: Kevin Jacobsen, currently Vice President of Financial Planning & Analysis, was appointed Senior Vice President and Chief Financial Officer, effective April 1, 2018.
- Compensation Adjustment: Mr. Jacobsen's base salary will increase to $500,000, and his short-term incentive target will rise from 50% to 80% of his salary, effective April 1, 2018.
- Equity Grant: On April 2, 2018, Mr. Jacobsen will receive stock options with an aggregate fair value of $200,000 (vesting over four years) and performance shares with an aggregate target fair value of $200,000.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business performance. No specific risks or contingencies related to financial operations are disclosed in this document, other than the standard transition of executive duties.
Investor Verification Checklist
- Verify the exact transition timeline between Mr. Robb's retirement (March 31, 2018) and Mr. Jacobsen's start date (April 1, 2018).
- Confirm the vesting schedule details for the $200,000 stock options and performance shares granted to Mr. Jacobsen.
- Review the press release filed as Exhibit 99.1 for additional context on the leadership transition.